NASDAQ:AXGN
Axogen, Inc.
Axogen, Inc.'s revenue grew 20.2% in fiscal 2025 to $225.2M while operating margin fell to −3.5%. Free cash flow was −$2.9M, −1.3% of revenue, and the diluted share count rose 4.1%.Summary generated from Axogen, Inc.'s SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$225.2M
Revenue growth+20.2%
Revenue, 5-yr CAGR+14.9%
Gross margin74.3%
Operating margin−3.5%
Net margin−7.0%
ROIC−4.7%
Return on equity−13.5%
Debt / equity0.38
Free cash flow−$2.9M
FCF margin−1.3%
Share count change+4.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 127 | 139 | 159 | 187 | 225 |
| Operating income | −25 | −30 | −21 | −3 | −8 |
| Net income | −27 | −29 | −22 | −10 | −16 |
| Free cash flow | −41 | −36 | −20 | 1 | −3 |
Recent filings
- 8-KRegulation FD disclosure
Oct 1, 2026 - 8-K/AAmended entry into a material agreement
Sep 10, 2026 - 8-KEntry into a material agreement
Sep 10, 2026 - 4Insider transaction report
Sep 4, 2026 - 4Insider transaction report
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 29, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 8-KResults of a shareholder vote
Jun 23, 2026